Cardiometabolic Medicine

The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia.  These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.  

Our Tweetorials

Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.

Cancer-Associated VTE

1) Welcome to a new #accredited #tweetorial on a🗝️ topic in #cancer care & #vascular medicine: #VTE (#DVT and #PE). Cancer patients are at⬆️risk...

Foundations of DKD

2) This activity is accredited for #physicians #physicianassistants #nurses #NPs #pharmacists. Credit from past programs: https://t.co/Yr5ymo7iR0...

@Cardiomet_CE on Twitter

Your only source for ACCREDITED SoMe-delivered 

serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!

On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME.  Programs are presented by expert faculty in engaging and fully interactive format.  Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.

Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.

cardio-metFollow

Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!

cardio-met
Retweet on Twittercardio-met Retweeted
HanCardiomdHenry Han, MBBS, MD@HanCardiomd·
18h

SGLT2i have been shown to prevent cardiorenal complications in T2DM

SMARTEST Trial : A registry-based RCT comparing an SGLT2i and metformin as standard treatment of early stage #T2DM

#MedTwitter #CardioTwitter @DLBHATTMD @AndrewJSauer @DrMarthaGulati @mmamas1973 @ShelleyZieroth

Reply on Twitter 1530522253108072448Retweet on Twitter 153052225310807244832Like on Twitter 1530522253108072448120Twitter 1530522253108072448
Load More...